Hannover, Germany

Peter Colin Gregory

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Peter Colin Gregory: Pioneering Advancements in Lipase Variants for Pharmaceutical Applications

Introduction: Peter Colin Gregory is a notable inventor based in Hannover, Germany, known for his significant contributions to the field of biochemistry, particularly in the development of lipase variants for pharmaceutical use. With a portfolio of five patents, Gregory has established himself as a prominent figure in the innovation landscape.

Latest Patents: One of Peter Colin Gregory's latest patents focuses on lipase variants designed for pharmaceutical applications. This patent discusses the pharmaceutical use of lipases, specifically those comprising amino acids 1-269 of SEQ ID NO: 2, which may be used in combination with a protease and/or an amylase. The medical indications highlighted within this invention address a range of digestive disorders, including pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and diabetes type II. The lipases developed under this innovation demonstrate enhanced digestion performance in vitro, improved activity in a neutral pH range, increased stability at low pH, resistance against protease degradation, and stability in the presence of pepsin and bile salts. Additionally, the invention includes methods for evaluating the digestion performance of these lipases in vitro.

Career Highlights: Peter Colin Gregory's career is marked by his significant work with leading organizations, most notably Novozymes A/S and Novozymes, Inc. His time at these companies has allowed him to explore and refine his innovative ideas, leading to the development of groundbreaking products in the field of enzyme technology.

Collaborations: Throughout his journey, Peter Colin Gregory has collaborated with other prominent professionals in the industry, including Allan Svendsen and Signe Eskildsen Larsen. These partnerships have facilitated the exchange of knowledge and ideas, which has been crucial in advancing his research and innovation.

Conclusion: Peter Colin Gregory has made considerable strides in the realm of pharmaceutical applications through his innovative work on lipase variants. His expertise and dedication to improving digestive health through enzyme technology position him as a significant contributor to the field of biochemistry and medicine. As he continues to develop new innovations, the impact of his work will undoubtedly resonate within the healthcare sector, benefiting patients with various digestive disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…